semaglutide adolescent obesity trial 2022 Half of children given 'skinny jab' no longer clinically obese, study finds | Once-Weekly Semaglutide in Adults with

So overall, we would think, but don't know yet because we don't have the results, that this is a group of patients that would have a fairly low event rate for major adverse cardiovascular events, which is what's being looked at in Select and as a secondary endpoint, these kidney outcomes

Doctors may still prescribe it off-label for weight management in certain cases, but this is less common

ROSE-010, a GLP-1 analog, was tested in a randomized, placebo-controlled clinical trial for treating acute pain in IBS patients [56]

[1] If side effects significantly impair your quality of life despite timing adjustments, your prescriber may consider dose modification or alternative treatment options